Entrada Therapeutics Inc
Ownership
Ownership Structure
Who owns Entrada Therapeutics Inc (TRDA)? This page shows the largest institutions and funds, the ownership structure and the latest insider transactions. 51.6% of the shares are freely tradable; institutional investors hold 78.7%.
Largest Shareholders
Institutions
| Name | Stake (%) | Shares | Change (%) | Date |
|---|---|---|---|---|
| Baker Bros Advisors LP | 13.03 | 5,072,730 | +0.0 | 03/31/2026 |
| 5AM Venture Management, LLC | 10.42 | 4,056,379 | +0.0 | 06/30/2026 |
| BlackRock Inc | 6.06 | 2,358,793 | +9.9 | 03/31/2026 |
| Merck & Co Inc | 4.47 | 1,739,768 | +0.0 | 06/30/2026 |
| Vanguard Capital Management, LLC | 3.23 | 1,256,013 | +0.0 | 03/31/2026 |
| MPM Oncology Impact Management LP | 3.22 | 1,253,053 | +0.0 | 06/30/2026 |
| TCG Crossover Management, LLC | 2.72 | 1,060,230 | -53.7 | 06/30/2026 |
| Wellington Management Company LLP | 2.45 | 954,419 | -7.8 | 06/30/2026 |
| Millennium Management LLC | 1.96 | 763,959 | +47.1 | 06/30/2026 |
Funds
| Name | Stake (%) | Shares | Change (%) | Date |
|---|---|---|---|---|
| Vanguard MStar Total Stk Mkt Idx Invest | 2.45 | 953,727 | +0.0 | 07/31/2026 |
Largest reported positions according to regulatory filings; stake as a percentage of shares outstanding, change versus the previous filing. Source: fundamentals data.
Insider holdings
| Person | Role | Shares | Value | As of | Type |
|---|---|---|---|---|---|
| Mpm Bioventures 2018, L.p. | 10% Owner | 3,885,115 | 26,807,294 $ | Sep 9, 2026 | indirect |
| MPM BioVentures 2014, L.P. | 10% Owner | 3,885,115 | 26,807,294 $ | Sep 9, 2026 | indirect |
| 5AM Ventures V, L.P. | 10% Owner | 2,783,781 | 19,208,089 $ | Aug 7, 2026 | direct |
| Parmar Kush | Director | 2,691,337 | 18,570,225 $ | Aug 10, 2026 | indirect |
| Doshi Dipal | CEO | 517,290 | 3,569,301 $ | Sep 2, 2026 | direct |
| Sethuraman Natarajan | President, Research & Develop. | 214,238 | 1,478,242 $ | Sep 2, 2026 | direct |
| Dowden Nathan J | President & COO | 196,060 | 1,352,814 $ | Sep 2, 2026 | direct |
| Wentworth Kory James | Chief Financial Officer | 117,277 | 809,211 $ | Sep 2, 2026 | direct |
Holdings as of each person's most recent SEC Form 4 filing — excluding options and RSUs, which are not shares yet. Holdings may have changed between two filings.
Insiders
Insider Transactions
| Date | Person | Role | Type | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Sep 9, 2026 | Mpm Bioventures 2018, L.p. | 10% Owner | Sell | 28,837 | 7.13 | 205,608 |
| Sep 9, 2026 | MPM BioVentures 2014, L.P. | 10% Owner | Sell | 28,837 | 7.13 | 205,608 |
| Sep 8, 2026 | Mpm Bioventures 2018, L.p. | 10% Owner | Sell | 192,500 | 7.41 | 1,426,425 |
| Sep 8, 2026 | MPM BioVentures 2014, L.P. | 10% Owner | Sell | 192,500 | 7.41 | 1,426,425 |
| Sep 4, 2026 | Mpm Bioventures 2018, L.p. | 10% Owner | Sell | 38,500 | 7.11 | 273,735 |
| Sep 4, 2026 | MPM BioVentures 2014, L.P. | 10% Owner | Sell | 38,500 | 7.11 | 273,735 |
| Sep 3, 2026 | Mpm Bioventures 2018, L.p. | 10% Owner | Sell | 32,263 | 7.17 | 231,326 |
| Sep 3, 2026 | MPM BioVentures 2014, L.P. | 10% Owner | Sell | 32,263 | 7.17 | 231,326 |
| Sep 2, 2026 | Sethuraman Natarajan | President, Research & Develop. | Other | 2,079 | 7.14 | 14,852 |
| Sep 2, 2026 | Dowden Nathan J | President & COO | Other | 2,528 | 7.14 | 18,060 |
| Sep 2, 2026 | Wentworth Kory James | Chief Financial Officer | Other | 1,733 | 7.14 | 12,380 |
| Sep 2, 2026 | Doshi Dipal | CEO | Other | 8,724 | 7.14 | 62,323 |
| Sep 2, 2026 | Mpm Bioventures 2018, L.p. | 10% Owner | Sell | 25,131 | 7.19 | 180,692 |
| Sep 2, 2026 | MPM BioVentures 2014, L.P. | 10% Owner | Sell | 25,131 | 7.19 | 180,692 |
| Sep 1, 2026 | Mpm Bioventures 2018, L.p. | 10% Owner | Sell | 29,088 | 7.06 | 205,361 |
| Sep 1, 2026 | MPM BioVentures 2014, L.P. | 10% Owner | Sell | 29,088 | 7.06 | 205,361 |
| Aug 31, 2026 | Mpm Bioventures 2018, L.p. | 10% Owner | Sell | 44,259 | 6.99 | 309,370 |
| Aug 31, 2026 | MPM BioVentures 2014, L.P. | 10% Owner | Sell | 44,259 | 6.99 | 309,370 |
| Aug 28, 2026 | Mpm Bioventures 2018, L.p. | 10% Owner | Sell | 3,733 | 7.01 | 26,168 |
| Aug 28, 2026 | MPM BioVentures 2014, L.P. | 10% Owner | Sell | 3,733 | 7.01 | 26,168 |
| Aug 27, 2026 | Mpm Bioventures 2018, L.p. | 10% Owner | Sell | 38,922 | 7.20 | 280,238 |
| Aug 27, 2026 | MPM BioVentures 2014, L.P. | 10% Owner | Sell | 38,922 | 7.20 | 280,238 |
| Aug 26, 2026 | MPM BioVentures 2014, L.P. | 10% Owner | Sell | 14,569 | 7.06 | 102,857 |
| Aug 26, 2026 | Mpm Bioventures 2018, L.p. | 10% Owner | Sell | 14,569 | 7.06 | 102,857 |
| Aug 25, 2026 | MPM BioVentures 2014, L.P. | 10% Owner | Sell | 26,522 | 7.54 | 199,976 |
| Aug 25, 2026 | Mpm Bioventures 2018, L.p. | 10% Owner | Sell | 26,522 | 7.54 | 199,976 |
| Aug 24, 2026 | MPM BioVentures 2014, L.P. | 10% Owner | Sell | 21,623 | 7.34 | 158,713 |
| Aug 24, 2026 | Mpm Bioventures 2018, L.p. | 10% Owner | Sell | 21,623 | 7.34 | 158,713 |
| Aug 10, 2026 | Parmar Kush | Director | Sell | 92,444 | 7.00 | 647,108 |
| Aug 7, 2026 | Parmar Kush | Director | Sell | 52,317 | 6.85 | 358,371 |
| Aug 7, 2026 | 5AM Ventures V, L.P. | 10% Owner | Sell | 52,317 | 6.85 | 358,371 |
| Aug 6, 2026 | Parmar Kush | Director | Sell | 10,494 | 7.00 | 73,458 |
| Aug 6, 2026 | 5AM Ventures V, L.P. | 10% Owner | Sell | 10,494 | 7.00 | 73,458 |
| Jul 31, 2026 | Parmar Kush | Director | Sell | 1,718 | 6.85 | 11,768 |
| Jul 31, 2026 | 5AM Ventures V, L.P. | 10% Owner | Sell | 1,718 | 6.85 | 11,768 |
| Jul 30, 2026 | Parmar Kush | Director | Sell | 114,756 | 6.93 | 795,259 |
| Jul 30, 2026 | 5AM Ventures V, L.P. | 10% Owner | Sell | 114,756 | 6.93 | 795,259 |
Reportable transactions by officers and major shareholders from SEC Form 4 filings. "Other" includes things like stock grants and option exercises without a buy/sell character. View all insider transactions →
Data as of: September 17, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.